US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

KraneShares MSCI All China Health Care Index ETF

18.54

-0.3850-2.03%

Post-market: 18.540.00000.00%19:30 EDT

Volume:64.75K

Turnover:1.20M

Market Cap:107.55M

PE:- -

High:18.87

Open:18.87

Low:18.44

Close:18.93

52wk High:21.88

52wk Low:14.38

Shares:5.80M

Float Shares:5.80M

Volume Ratio:2.51

T/O Rate:1.12%

Dividend:0.71

Dividend Rate:3.86%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

CSPC Pharma's SYS6090 (JMT108) Receives FDA Fast Track Designation for MSS/pMMR Metastatic Colorectal Cancer Treatment

BEONE MEDICINES Reports Strong First-Half Profit Surge of 385.8%

Southbound Capital Insights: Net Buying Hits HK$453 Million, Innovent Bio Faces Heavy Selling After Earnings Surge

CSPC Pharma Says FDA Grants Fast Track Status to Sys6090 for MSS/pMMR Metastatic Colorectal Cancer

CSPC Pharma's SYS6010 Achieves Primary Endpoint in Phase III Trial for EGFR-Mutant NSCLC Patients

CSPC Pharmaceutical - Sys6090 (Jmt108) Granted Fast Track Designation by U.S. FDA for Mss/Pmmr Mcrc

THOMSON REUTERS

CSPC Pharmaceutical - Sys6010 Meets Primary Endpoint of Progression-Free Survival in Phase Iii Synstar-01 Study

THOMSON REUTERS

CSPC Pharmaceutical Group Stock Rallies 1.2% in Hong Kong, Underperforms Competitors

CICC Maintains Outperform Rating on Innovent Biologics with Target Price Set at HK$118.30

-BUZZ-China's Innovent Biologics Hits All-Time High on H1 Growth

Hong Kong Biotech Sector Surges Again as Innovative Drug Stocks Lead Gains, INNOVENT BIO Hits Record High

China, HK Stocks Track Global Tech Rebound; Gold Miners Rally

Hong Kong's SSY Group H1 Profit Rises on Infusion Solutions Growth

Sihuan Pharmaceutical H1 Profit Jumps on Medical Aesthetics Unit Strength

Morning Market Wrap: Hong Kong Shares Rise 0.68% as Copper Stocks Take the Lead

Mainland Benchmarks Edge Higher in Morning Trade; Nonferrous Metals and Brokerages Lead While Optical Modules Retreat; Hang Seng and Tech Index Climb Over 1% on Biotech Surge

China's Akeso Jumps on Progress of Immunotherapy Drug for Cancer Treatment

AKESO Surges Over 9% in Session as Evonex Achieves Positive Phase III Results in Biliary Tract Cancer

Akeso's Ivonescimab Meets Primary Endpoint in Phase 3 Biliary Tract Cancer Trial

MT Newswires Live

Akeso Says Ivonescimab Plus Chemo Meets Primary Endpoint

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/KURE/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KURE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","market":"US","secType":"STK","nameCN":"KraneShares MSCI All China Health Care Index ETF","latestPrice":18.54,"timestamp":1788206400000,"preClose":18.925,"halted":0,"volume":64746,"hourTrading":{"tag":"盘后","latestPrice":18.54,"preClose":18.54,"latestTime":"19:30 EDT","volume":10,"amount":185.4,"timestamp":1788219002391,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.020343461030383172,"floatShares":5800979,"shares":5800979,"eps":0,"marketStatus":"Closed","change":-0.385,"latestTime":"08-31 16:00:00 EDT","open":18.87,"high":18.87,"low":18.44,"amount":1197156.0003479999,"amplitude":0.022721,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788249600000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":18.925,"sharesOutstanding":4750002,"nav":19,"aum":110211439.71,"dividendRate":0.038554,"bidAskSpread":0.005823,"postHourTrading":{"tag":"盘后","latestPrice":18.54,"preClose":18.54,"latestTime":"19:30 EDT","volume":10,"amount":185.4,"timestamp":1788219002391,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.508893,"impliedVol":0.2767,"impliedVolPercentile":0.5737},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","floatShares":5800979,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.508893,"shares":5800979,"dividePrice":0.7148,"high":18.87,"amplitude":0.022721,"preClose":18.925,"low":18.44,"week52Low":14.3797,"pbRate":"--","week52High":21.875,"institutionHeld":0,"latestPrice":18.54,"eps":0,"divideRate":0.038554,"volume":64746,"delay":0,"ttmEps":0,"open":18.87,"prevYearClose":17.04,"prevWeekClose":18.925,"prevMonthClose":17.28,"prevQuarterClose":15.747,"fiveDayClose":18.6163,"twentyDayClose":17.0849,"sixtyDayClose":15.23},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KURE\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"KURE","amount":0.714689,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-23"},{"date":"2024-12-17","symbol":"KURE","amount":0.18361,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-18"},{"date":"2023-12-18","symbol":"KURE","amount":0.112844,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2023-12-20","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-20"},{"market":"US","date":"2022-12-28","symbol":"KURE","amount":0.010399,"defaultRemindTime":1672237800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2021-12-29","symbol":"KURE","amount":4.053448,"defaultRemindTime":1640788200000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KURE\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-26","recordDate":"2018-12-27","paymentDate":"2018-12-28","value":0.039344,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":0.057325,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.000109,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":4.053448,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.010399,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KURE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KURE\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1119638338","title":"CSPC Pharma's SYS6090 (JMT108) Receives FDA Fast Track Designation for MSS/pMMR Metastatic Colorectal Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1119638338","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119638338?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:18","pubTimestamp":1787739482,"startTime":"0","endTime":"0","summary":"CSPC Pharma (01093) has announced that its first-in-class PD-1/IL-15 bispecific fusion protein, SYS6090 (JMT108), has been granted Fast Track designation by the U.S. Food and Drug Administration...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5MMRT66.SGD","LU0140636845.USD","LU1960683339.HKD","BK4585","LU1993786604.SGD","BK1191","LU1226288253.USD","LU1152091754.HKD","01093","IE00BZ08YR35.GBP","LU0072913022.USD","LABU","LU0314109678.HKD","LU1226288170.HKD","LU0501845795.SGD","IE00B543WZ88.USD","LU0315179316.USD","LU0880133367.SGD","SG9999004220.SGD","LU1328277881.USD","IE0008369823.USD","IE0008368742.USD","LU1807302812.USD","BK4588","BK4113","LU1226287529.USD","IE00BZ08YS42.EUR","LU1813983027.USD","LU1152091168.USD","BK1521","LU1951186391.HKD","LU1226287792.SGD","KURE","LU2039709279.SGD","MSS","BK1515","LU1226287875.USD","IE00B031HY20.USD","LU0326950275.SGD","LU0067412154.USD","HK0000165453.HKD","IE00BZ08YT58.USD","LU1008478684.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107537379","title":"BEONE MEDICINES Reports Strong First-Half Profit Surge of 385.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1107537379","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107537379?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:16","pubTimestamp":1787739404,"startTime":"0","endTime":"0","summary":"BEONE MEDICINES (06160) has unveiled its interim results for the six months ended June 30, 2026, posting a net profit of $464 million, a substantial year-on-year increase of 385.8%.The company's...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1303224171.USD","BK1500","LU1719994722.HKD","LU1969619763.USD","KURE","LU1770034418.SGD","BK4585","LU0828237510.HKD","LU1251922891.USD","BK4588","BK1583","BK1588","06160","BK1161","BK4526","LU0307460666.USD","BK0239","LU2328871848.SGD","LU0228659784.USD","688235","ONC","BK4139","LU0588546209.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124902197","title":"Southbound Capital Insights: Net Buying Hits HK$453 Million, Innovent Bio Faces Heavy Selling After Earnings Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1124902197","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124902197?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:11","pubTimestamp":1787739111,"startTime":"0","endTime":"0","summary":"On August 26th in the Hong Kong stock market, southbound capital recorded a net buy of HK$453 million. Specifically, the Shanghai-Hong Kong Stock Connect saw a net sell of HK$1.125 billion, while the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0244354667.USD","LU0502904849.HKD","KURE","BK1583","LU2097828474.EUR","HK0000165453.HKD","LU2488822045.USD","LU2097828714.EUR","LU2097828557.USD","LU2328871848.SGD","LU0463099449.HKD","LU2097828631.EUR","LU2242644610.SGD","LU1969619763.USD","BK1589","01801","LU0455707207.USD","LU1188198961.HKD","BK1161","LU0326950275.SGD","LU2097828805.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662679768","title":"CSPC Pharma Says FDA Grants Fast Track Status to Sys6090 for MSS/pMMR Metastatic Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662679768","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662679768?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:11","pubTimestamp":1787739093,"startTime":"0","endTime":"0","summary":"CSPC Pharma says FDA grants Fast Track status to SYS6090 for MSS/pMMR metastatic colorectal cancerCSPC Pharmaceutical’s SYS6090 (JMT108) won US FDA Fast Track designation for MSS/pMMR metastatic color","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL2W16sV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5MMRT66.SGD","IE00BZ08YT58.USD","01093","IE00BZ08YS42.EUR","LU1328277881.USD","IE0008369823.USD","LU1226288253.USD","IE00B031HY20.USD","IE00BZ08YR35.GBP","LU1813983027.USD","LU1951186391.HKD","LU0067412154.USD","SG9999004220.SGD","IE0008368742.USD","LU0326950275.SGD","LU0072913022.USD","LU0880133367.SGD","LU1993786604.SGD","LU1226287529.USD","BK1515","HK0000165453.HKD","LU1152091754.HKD","LU1152091168.USD","LU1226287875.USD","LU1226288170.HKD","LU0315179316.USD","LU2039709279.SGD","LU0140636845.USD","BK1191","KURE","LU1008478684.HKD","IE00B543WZ88.USD","LU0314109678.HKD","LU1226287792.SGD","LU1807302812.USD","LU0501845795.SGD","LU1960683339.HKD","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115485763","title":"CSPC Pharma's SYS6010 Achieves Primary Endpoint in Phase III Trial for EGFR-Mutant NSCLC Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=1115485763","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115485763?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:10","pubTimestamp":1787739028,"startTime":"0","endTime":"0","summary":"CSPC PHARMA (01093) has announced that its investigational drug SYS6010 successfully met the predefined primary endpoint of progression-free survival (PFS) in the Phase III clinical study SYNSTAR-01....","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0008369823.USD","LU1152091754.HKD","LU1226287875.USD","IE00B031HY20.USD","KURE","LU1008478684.HKD","LU1152091168.USD","IE00BZ08YS42.EUR","LU1951186391.HKD","SG9999004220.SGD","LU0072913022.USD","LU1960683339.HKD","LU0501845795.SGD","LU1813983027.USD","LU1993786604.SGD","LU0315179316.USD","HK0000165453.HKD","BK1191","LU0880133367.SGD","IE00BZ08YR35.GBP","LU1226287792.SGD","LU1807302812.USD","IE00BZ08YT58.USD","BK1515","LU1226288253.USD","LU0314109678.HKD","LU1226288170.HKD","LU2039709279.SGD","LU1226287529.USD","LU1328277881.USD","III","IE00B5MMRT66.SGD","01093","LU0067412154.USD","IE0008368742.USD","IE00B543WZ88.USD","BK1521","LU0140636845.USD","BK4134","LU0326950275.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662797532","title":"CSPC Pharmaceutical - Sys6090 (Jmt108) Granted Fast Track Designation by U.S. FDA for Mss/Pmmr Mcrc","url":"https://stock-news.laohu8.com/highlight/detail?id=2662797532","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662797532?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:10","pubTimestamp":1787739002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N0I5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1226288170.HKD","BK1515","LU0067412154.USD","LU0140636845.USD","LU1226287792.SGD","LU2039709279.SGD","LU1152091168.USD","LU1328277881.USD","KURE","LU1152091754.HKD","IE0008369823.USD","HK0000165453.HKD","LU1993786604.SGD","IE00BZ08YT58.USD","BK1191","BK1521","LU1226287529.USD","LU1226287875.USD","SG9999004220.SGD","LU0880133367.SGD","LU1008478684.HKD","LU0315179316.USD","IE0008368742.USD","LU1951186391.HKD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","IE00BZ08YS42.EUR","LU1813983027.USD","IE00BZ08YR35.GBP","LU0072913022.USD","LU0326950275.SGD","LU1226288253.USD","01093","LU1807302812.USD","LU1960683339.HKD","LU0501845795.SGD","LU0314109678.HKD","IE00B031HY20.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662792719","title":"CSPC Pharmaceutical - Sys6010 Meets Primary Endpoint of Progression-Free Survival in Phase Iii Synstar-01 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2662792719","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662792719?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:01","pubTimestamp":1787738500,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N0KM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0067412154.USD","LU1993786604.SGD","BK1521","01093","IE0008368742.USD","LU1152091168.USD","LU1226287529.USD","LU1951186391.HKD","LU0072913022.USD","IE00B031HY20.USD","LU1807302812.USD","LU1813983027.USD","IE00BZ08YS42.EUR","LU0880133367.SGD","IE00BZ08YT58.USD","LU1328277881.USD","LU0315179316.USD","LU1226287792.SGD","LU1226288170.HKD","LU1960683339.HKD","LU1226288253.USD","BK1515","IE00B5MMRT66.SGD","LU0326950275.SGD","HK0000165453.HKD","LU1008478684.HKD","LU2039709279.SGD","IE0008369823.USD","SG9999004220.SGD","LU0501845795.SGD","LU0314109678.HKD","KURE","LU1226287875.USD","IE00B543WZ88.USD","BK1191","LU0140636845.USD","LU1152091754.HKD","IE00BZ08YR35.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662796413","title":"CSPC Pharmaceutical Group Stock Rallies 1.2% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662796413","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662796413?lang=en_us&edition=fundamental","pubTime":"2026-08-26 16:33","pubTimestamp":1787733180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. advanced 1.2% to 9.53 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.6% to 25652.97.This was the stock's third consecutive day of gains.CSPC Pharmaceutical Group Ltd. closed 18% short of its 52-week high of HK$11.63, which the company achieved Sept. 9.The stock demonstrated a mixed performance when compared to some of its competitors, as Sino Biopharmaceutical Ltd. rose 2.1%, SSY Group Ltd. rose 5.2%, and United Laboratories International Holdings Ltd. fell 0.8%.Trading volume totaled 190.3 million shares, compared to the 50-day average of 100.7 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328277881.USD","LU0501845795.SGD","IE00BZ08YT58.USD","KURE","LU0314109678.HKD","01093","SG9999004220.SGD","LU1993786604.SGD","LU1008478684.HKD","IE00B543WZ88.USD","LU1226287792.SGD","BK1191","LU2039709279.SGD","IE00B031HY20.USD","LU0880133367.SGD","LU1226288170.HKD","LU1152091168.USD","LU1951186391.HKD","LU0072913022.USD","LU0326950275.SGD","IE0008368742.USD","BK1521","LU1226287529.USD","IE00BZ08YS42.EUR","LU1960683339.HKD","LU0315179316.USD","LU0067412154.USD","LU1813983027.USD","LU0140636845.USD","IE0008369823.USD","LU1152091754.HKD","LU1807302812.USD","BK1515","HK0000165453.HKD","IE00B5MMRT66.SGD","LU1226288253.USD","IE00BZ08YR35.GBP","LU1226287875.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139243882","title":"CICC Maintains Outperform Rating on Innovent Biologics with Target Price Set at HK$118.30","url":"https://stock-news.laohu8.com/highlight/detail?id=1139243882","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139243882?lang=en_us&edition=fundamental","pubTime":"2026-08-26 14:11","pubTimestamp":1787724693,"startTime":"0","endTime":"0","summary":"CICC has released a research report stating that it maintains an outperform rating on INNOVENT BIO (01801), keeping its 2026 net profit attributable to shareholders forecast at RMB 2.43 billion....","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KURE","LU2097828474.EUR","LU0502904849.HKD","LU1969619763.USD","LU2097828805.USD","BK1161","BK1589","01801","LU2097828631.EUR","LU2097828714.EUR","LU0455707207.USD","LU0463099449.HKD","LU2097828557.USD","BK1583","LU2242644610.SGD","LU1188198961.HKD","LU2328871848.SGD","LU0326950275.SGD","HK0000165453.HKD","EWH","LU2488822045.USD","LU0244354667.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662540760","title":"-BUZZ-China's Innovent Biologics Hits All-Time High on H1 Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2662540760","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662540760?lang=en_us&edition=fundamental","pubTime":"2026-08-26 14:09","pubTimestamp":1787724588,"startTime":"0","endTime":"0","summary":"-BUZZ-China's Innovent Biologics hits all-time high on H1 growthAdds top pct gainer in key index in third bullet, earnings details in fourth bullet** Shares of China's Innovent Biologics1801.HKjump 12","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N03U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","LU2242644610.SGD","LU0244354667.USD","LU0455707207.USD","LU0463099449.HKD","LU2328871848.SGD","LU2097828631.EUR","LU1969619763.USD","LU2097828474.EUR","LU2097828714.EUR","BK1161","LU0502904849.HKD","LU1188198961.HKD","HK0000165453.HKD","01801","LU2097828805.USD","KURE","BK1589","LU2488822045.USD","LU0326950275.SGD","LU2097828557.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149059268","title":"Hong Kong Biotech Sector Surges Again as Innovative Drug Stocks Lead Gains, INNOVENT BIO Hits Record High","url":"https://stock-news.laohu8.com/highlight/detail?id=1149059268","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149059268?lang=en_us&edition=fundamental","pubTime":"2026-08-26 14:02","pubTimestamp":1787724134,"startTime":"0","endTime":"0","summary":"Hong Kong healthcare stocks continued their upward momentum on August 26, with innovative drug developers taking over the leadership baton from the CXO sector. Cansino Biologics Inc. soared more than...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","BK1574","LU2488822045.USD","LU0326950275.SGD","KURE","LU2097828557.USD","LU0502904849.HKD","MEDX","LU0244354667.USD","LNGR","BK1589","LU2242644610.SGD","159992","FLHK","01801","LU2328871848.SGD","LU1188198961.HKD","LU2097828631.EUR","LU0463099449.HKD","LU2097828714.EUR","LU0455707207.USD","LU2097828474.EUR","LU1969619763.USD","688185","159646","BK0239","06978","HK0000165453.HKD","BK1583","LU2097828805.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662640467","title":"China, HK Stocks Track Global Tech Rebound; Gold Miners Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2662640467","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662640467?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:27","pubTimestamp":1787718464,"startTime":"0","endTime":"0","summary":"China, HK stocks track global tech rebound; gold miners rallySHANGHAI, August 26 (Reuters)-China and Hong Kong stocks advanced on Wednesday, tracking a broader rebound in global markets as sentiment i","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N034:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0323240290.USD","VT","LU0261947096.USD","CXSE","LU0109391861.USD","COHH","LU1196710864.SGD","LU2399975544.HKD","02800","LU1814569148.SGD","LU2746668974.SGD","SG9999002224.SGD","BK1610","SPRX","BK1618","LU0039217434.USD","LU0143863198.USD","LU1720051108.HKD","LU0965509101.SGD","LU1770034418.SGD","LU1720051017.SGD","BABA","BK4608","ESLG","82800","BK4532","LU0531971595.HKD","BK4551","LU0395794307.EUR","LU2244417387.USD","LU1066053197.SGD","LU2413666699.HKD","LU0593848301.USD","LU0886674414.USD","LU0476273544.USD","LU0823397103.USD","LU1232071149.USD","LU2092937148.SGD","HSI","LU0210528500.USD","LU0862451837.USD","LU0965508806.USD","BK4527","LU2272731600.USD","SG9999006597.SGD","LU1119994496.HKD","LU0157215616.USD","LU0210526637.USD","LU2125910849.SGD","LU0553294199.USD","LU2097828557.USD","BK4612","LU1435385759.SGD","LU0543330566.HKD","LU2471134879.HKD","LU1145028129.USD","LU1988902786.USD","IE00BDCRKT87.USD","01801","LU0345770993.USD","BK4534","TTEQ","LU2476274308.USD","NVII","SG9999002828.SGD","HK0000306685.HKD","LU0511384066.AUD","IE00BZ1G4Q59.USD","LU0348723411.USD","LU2543165471.USD","LU1303224171.USD","LU1732800096.USD","LU0868486357.SGD","LU0516422952.EUR","SG9999001226.SGD","LU0117841782.USD","LU0762542818.HKD","IE00B543WZ88.USD","LU0791591158.USD","LU0943347566.SGD","LU2999663052.SGD","SGXZ99366536.SGD","LU1044874839.SGD","BK4141","IE0004091025.USD","LU0828237510.HKD","LU2265009873.SGD","LU0359201885.HKD","LU0823414478.USD","LU1400636657.SGD","LU2023251221.USD","LU1066051225.USD","BK1161","LU0819121731.USD","LU0449515922.USD","LU0823040885.USD","03419","LU0359202008.SGD","LU0862451753.SGD","LU2272731782.SGD","LU0140636845.USD","LU2294711713.HKD","LU0348735423.USD","LU0354030511.USD","LU0577902298.EUR","LU0630378429.USD","LU1712237335.SGD","LU0048584097.USD","LU1868837136.USD","SGXZ90724238.SGD","09988","LU1568876335.HKD","LU1261432733.SGD","BK1575","LU2491050071.SGD","IE00BWXC8680.SGD","LU0345768153.USD","IE00BMPRXQ63.HKD","LU0211328371.USD","LU0328353924.USD","LU0267386448.USD","LU0463099449.HKD","LU2237443978.SGD","BK1586","LU0029864427.USD","LU0531970944.HKD","LU1969619763.USD","IE00BMPRXR70.SGD","LU0079474960.USD","LU1791710400.SGD","LU0274383776.USD","ARTY","IE0004445239.USD","BK4587","IE00BQXX3F31.USD","BK1502","LU0106259558.USD","LU0823414551.USD","LU1242518931.SGD","LU2168563687.JPY","LU2463028550.USD","HK0000304805.HKD","LU0293314216.USD","LU0868494708.USD","LU0577902611.USD","ESUM","GB00BDT5M118.USD","FOTO","LU0307460666.USD","LITU","TTXU","IE00BJLML261.HKD","LU0588546209.SGD","GAMR","LU2360107168.USD","LU0011963245.USD","LU2458330169.SGD","SG9999006514.SGD","LU2413666426.HKD","LU0708995583.HKD","USD","LU0675040207.SGD","LU0128525929.USD","LU1674673691.USD","LU0197773160.USD","LU0158827781.USD","LU0310799852.SGD","LU0494093205.USD","LU1116320901.HKD","NULC","IE00B1BXHZ80.USD","SNVDAmain","IE00B19Z4B17.USD","IE0034235188.USD","LU2750360997.AUD","IE00BKPKM429.USD","LU2106854487.HKD","LU2264538146.SGD","ABFL","LU0594300419.USD","NVYY","LU1839511570.USD","SGXZ62798434.SGD","LU1280957306.USD","LU0572939691.SGD","LU0737861772.HKD","HK0000819398.USD","IE00B1XK9C88.USD","LU0049853897.USD","LU2125909593.SGD","LU1400636491.USD","LU2168564222.USD","SG9999018857.SGD","LU0012050646.USD","LU1803068979.SGD","LU0323591593.USD","IE00BKVL7J92.USD","LU1934455863.HKD","LU0964807845.USD","LU1989772923.USD","LU0347712357.USD","LU0689626769.HKD","LU2322448957.HKD","LU0502904849.HKD","SG9999018865.SGD","BK1142","LU0890818403.SGD","LU2065171311.SGD","LU0048597586.USD","IE0004086264.USD","LU0456846285.SGD","LU0466842654.USD","LU0143551892.USD","LU1316542783.SGD","NVDO","LU0823041008.USD","LU2133065610.SGD","LU0455707207.USD","LU0762540952.USD","AIFD","07788","COHC","LU2750360641.GBP","SG9999015986.USD","83115","LU0823413660.USD","LU1282649067.USD","LU2471134952.CNY","LU0661504455.SGD","LU1961090484.USD","LU0469268626.HKD","SOXY","LU0240878834.USD","LU2293587155.HKD","LU2023250504.SGD","LU1642822529.SGD","LU1951198990.SGD","LU0130518102.USD","LU0472753341.HKD","IE00B4YYXB79.USD","LU0240877869.USD","LU0047713382.USD","LU0648000940.SGD","BK4605","LU1066051811.HKD","LU0788109477.HKD","SOXX","LU1810669033.SGD","LU0235996351.USD","LU1923622614.USD","LU0310800379.SGD","NVDL","SG9999002232.USD","BK4585","LU0106252389.USD","02833","BK4148","LU1880383366.USD","LU2063271972.USD","LU2097828631.EUR","SNPE","LU0642271901.SGD","SGXZ23171101.USD","LU0345768740.USD","LU0165289439.USD","LU0865486749.SGD","LU0708994859.HKD","LU0823038988.USD","BK4614","LU2168564065.EUR","LU0823421333.USD","LU1993786604.SGD","SGXZ80539844.SGD","3NVD.UK","HK0000914660.USD","LU0444973449.USD","LU2505996509.AUD","IE00B5TLWC47.USD","LU0540923850.HKD","LU2054465674.USD","LITZ","LU0244354667.USD","LU0561508036.HKD","LU1794554557.SGD","SGXZ51526630.SGD","LU1992135399.USD","LU2077746001.SGD","SG9999000459.SGD","LU2347655156.SGD","BK1521","LU2290526834.HKD","IE0008368304.USD","ALBmain","LU0965509010.AUD","IE00B3SWFQ91.USD","LU1852331112.SGD","LU0516423091.SGD","IE0003895053.USD","LU0557290698.USD","LU0181495838.USD","LU0831103253.SGD","AGOX","LU0345769631.USD","LU0143863784.USD","LU0345776255.USD","LU2226246903.HKD","IE00BZ08YR35.GBP","LU1623119135.USD","LU2237957811.SGD","IE00B7SZL793.SGD","SPTE","LU0061477393.USD","LU1956131251.USD","LU2097344431.USD","LU0081259029.USD","LU1323998911.USD","LU2097828714.EUR","IE00B5MMRT66.SGD","LU2097828474.EUR","LU2931357623.SGD","BK1588","BK4548","LU2552382058.USD","IE00BJJMRX11.SGD","LU0456827905.SGD","IE00B5949003.HKD","LU0096364046.USD","LU0323239441.USD","LU2125909759.SGD","LU2237443382.USD","CLSE","LU1868836591.USD","LU0061474960.USD","IE00B19Z8W00.USD","LU0061475181.USD","LU1568876251.USD","LU2462591350.SGD","SG9999002562.SGD","LU1066051498.USD","LU0608807946.USD","HK0000304797.USD","LUMA","LU2756315664.SGD","IE00BJJMRY28.SGD","LU0541502299.USD","LU0169518387.USD","HHImain","LU2236285917.USD","LU0320764599.SGD","IE0034235303.USD","LU2592432038.USD","LU2637965513.SGD","SG9999001689.USD","LU0797268264.HKD","LU0225283273.USD","LU0672654166.SGD","LU1282649141.HKD","LU1655091459.SGD","LU2065169927.USD","LU0588545490.SGD","LU0320765059.SGD","LU2092627202.USD","LU0265550359.USD","BK4567","SG9999000327.SGD","IE00B3S45H60.SGD","IE00BZ08YS42.EUR","LU1127390331.HKD","LU2860962120.EUR","NVDX","NVDA","LU0828237940.HKD","LU0871576103.HKD","07200","LU0672654240.SGD","LU0345769128.USD","LITC","LU0795875086.SGD","LU1935043536.SGD","LU0979878070.USD","LU1153585028.USD","LU1051768304.USD","LU0138981039.USD","IE00BFSS8Q28.SGD","LU2381873111.SGD","IE00BQXX3C00.GBP","BK4549","NVDS","LU2148611432.USD","LU0605514214.HKD","LU0327786744.USD","IE00BQXX3D17.EUR","SG9999014567.USD","LU2505996681.GBP","LU0354030438.USD","IETC","LU0053666078.USD","LU1935043023.USD","LU0545039389.USD","LU0431992006.USD","LU0329678170.USD","LU0072462426.USD","LU0689472784.USD","LU0205194284.USD","LU0348816934.USD","LU0477156797.USD","LU0949170772.SGD","LU2039709279.SGD","LU2250418816.HKD","HK0000107257.USD","LU2430703251.USD","LU2125154935.USD","LU0528227936.USD","LU2168564149.EUR","LU0417516902.SGD","LU0588545904.SGD","LU0942090050.USD","IE000YTNTUN2.SGD","VGT","LU2294711473.HKD","LU2357305700.SGD","TEK","LU0831093199.SGD","SMHX","IE00B775H168.HKD","LU1267930573.SGD","HK0000532082.HKD","LU0029874905.USD","LU0107464264.USD","LU0251132253.USD","LU0287142896.SGD","LU1037948897.HKD","LU2271345857.HKD","LU2430703095.HKD","LU1035775433.USD","IE00BDRTCR15.USD","LU1868836757.USD","SG9999004303.SGD","LU1366192091.USD","LU1868838027.USD","LU0228367735.SGD","IXN","LU0029875118.USD","03115","LU0488056044.USD","LU0918141887.USD","LU0390134368.USD","BK1589","LU0820561818.USD","LU1035773651.USD","LU0449509016.USD","LU2089985449.USD","SG9999014914.USD","SHOC","LU2237443622.USD","LU2954938101.SGD","LU1188198961.HKD","LU1282649810.SGD","IE00BK4W5L77.USD","LU0820562030.AUD","LU1720050803.USD","LU1224444064.USD","BK4503","LU2028103732.USD","LU1951200564.SGD","LU1699723380.USD","LU1732799900.SGD","LU0051755006.USD","LU0708995401.HKD","LU0158827948.USD","HK0000914686.HKD","SG9999015341.SGD","IE00B0JY6N72.USD","LU2097828805.USD","BK4529","LU2237438978.USD","FTEC","LU2242644610.SGD","LU2045819591.USD","LU2286300806.USD","LU0170899867.USD","89988","IE00BJTD4V19.USD","LU0608807433.USD","LU2361044949.HKD","LU0080751232.USD","NVD2.UK","2NVD.UK","COHQ","LU1282648689.USD","IE000KEQY171.SGD","NVDB","LU2420271590.USD","BK1591","NVDW","LU0651946864.USD","LU1551013342.USD","LU0011850046.USD","LU0634319403.HKD","LITG","BK4581","LU1718418525.SGD","NVC","LU0097036916.USD","AIPI","KWEB","LU1769817096.USD","LU0873338254.USD","LU1808992512.USD","LU1244550577.SGD","BK1517","LU0175139822.USD","IE0034224299.USD","LU2449936058.SGD","NVDU","IE00BHPRN162.USD","LU1481107354.HKD","BK1583","NVDY","LU0957791311.USD","IE0003U64NQ7.SGD","IE0032431581.USD","LU0594300179.USD","LU1244550494.USD","SG9999014674.SGD","LU1044875133.USD","SG9999014898.SGD","LU0163747925.USD","LU0234570918.USD","FDTX","LU0348805143.USD","LU1069347547.HKD","ANV","LU0417517546.SGD","LU0650527681.SGD","LU0918141705.HKD","LITX","LU1721428933.USD","LU1251922891.USD","LU2417539215.USD","LU0259732245.USD","LDEM","LU0056508442.USD","USXF","LU0577902371.SGD","LU1691799644.USD","LU0256863811.USD","LU2087589342.USD","LU0345770308.USD","LU0444971666.USD","LU0724617625.USD","LU2097344357.USD","LU0057025933.USD","LU2471134796.USD","LU0326950275.SGD","SG9999002463.SGD","TRFK","LU0256863902.USD","BK4157","IE0031619046.USD","LU1868837300.USD","LU1037948541.HKD","LU2476274720.SGD","LU0211977185.USD","LU2089284900.SGD","LU1366334578.USD","LU0173614495.USD","LU0308772762.SGD","NVD","LU2125154778.USD","LU1633808545.USD","BK1501","LU1571399168.USD","BK4550","LU0348783233.USD","IE00B19Z8X17.USD","LU2471134523.USD","LU0289960550.SGD","LU1051769294.HKD","LU1323610961.USD","LU1328615791.USD","LU1629891620.HKD","LU0054450605.USD","IE00B19Z9505.USD","LU0127658192.USD","LU0320764243.SGD","LU2087621335.USD","IE0034235295.USD","LU1084165304.USD","LU1813983027.USD","LU1815336760.USD","LU1211504680.USD","SG9999015952.SGD","LU0276348264.USD","LU2047632596.USD","LU0261950983.USD","LU1992135472.HKD","LU0149534421.HKD","LU0823434583.USD","LU2237443465.HKD","BK4543","LU0289739343.SGD","LU1048596156.SGD","07500","LU1069344957.HKD","LU1044876610.USD","LU0823039010.USD","LU0203201768.USD","BK4598","JGRO","LU0196878994.USD","NVDS.UK","LU2462157665.USD","SG9999014542.SGD","NVDD","LU1807302812.USD","LU1688375341.USD","LU0577902538.SGD","LU0329678337.USD","LU2237443549.SGD","LU1267930730.SGD","LU2487616109.SGD","SG9999014880.SGD","LU1868837565.USD","LU0211327993.USD","LU0572940350.SGD","513600","SG9999015978.USD","LU0130103400.USD","LU0719512351.SGD","LU2191332357.HKD","LU1861215975.USD","LU0215105999.USD","LU2433249047.HKD","LU1935042991.SGD","LU2458330243.SGD","LU0082616367.USD","HBBD.SI","WISE","LU1003077747.HKD","IE00B66KJ199.SGD","LU1048588211.SGD","LU1105468828.SGD","LU0823426480.USD","LU0198837287.USD","LU2237957902.USD","LU0210527791.USD","LU0856984785.SGD","LITE","LU2602419157.SGD","IE00BYXW3230.USD","LU2403377893.USD","BK4020","LU0106261372.USD","LU0054237671.USD","LU1439103000.SGD","LU0117844026.USD","EGGY","KURE","LU1868836914.USD","IE0004445015.USD","LU1674673428.USD","09115","LU2168564495.EUR","LU0417516571.SGD","ILDR","LU2247934214.USD","LU1983260115.SGD","LU1328277881.USD","LU1778281490.HKD","LU1719994722.HKD","LU0823426308.USD","LU2347655073.USD","LU2896262040.SGD","LU0106261612.USD","LU0589944569.HKD","LU0588545730.USD","LU0640798160.USD","LU0164880469.USD","LU1515016050.SGD","LU0229945570.USD","LU0516423174.USD","LU2430703178.SGD","LU0048580855.USD","LU0254981946.USD","LU0348788117.USD","NVD3.UK","LU0316494557.USD","LU0238689110.USD","LU0784639295.USD","LU0124676726.USD","IE00BPRC5H50.USD","SG9999001093.SGD","DIPS","LU1960683339.HKD","LU0006306889.USD","SG9999000418.SGD","LU1201861165.SGD","LU0149721374.USD","LU0541501648.USD","LU1821325948.USD","HSTECH","LU1989764748.USD","LU1934455194.USD","LU0069063385.USD","LU2108987350.USD","LU2328871848.SGD","LU2756315318.SGD","TYLG","LU1551013425.SGD","LU0315178854.USD","LU1917777945.USD","LU1981816686.USD","LU0738911758.USD","SG9999001051.SGD","HK0000320264.USD","LU1064131342.USD","LU1804176565.USD","LU0228659784.USD","LU0231483743.USD","LU1366334651.USD","LU0821914370.USD","LU2125910500.SGD","THMR","LU1880383440.USD","LU1935042215.USD","IE00BZ08YT58.USD","LU0957808578.USD","LU2249611893.SGD","BK4588","IE00BJTD4N35.SGD","LU2257852520.SGD","LU2491050154.USD","LU1989764664.SGD","LU0072462343.USD","EFIV","LU0572944931.SGD","LU2087625088.SGD","SG9999014575.USD","MHImain","BK1584","LU0096362180.USD","LU0516422366.SGD","LU1861220033.SGD","LU0315179316.USD","LU0052750758.USD","LU0094547139.USD","LU0417516738.SGD","LU0164872284.USD","LU0061474705.USD","LU2065170008.USD","BK1608","LU0640476718.USD","LU0516422440.USD","LU1923622291.USD","LU0889565833.HKD","LU2211815571.USD","METV","SG9999001424.SGD","CHAT","LU1989772840.SGD","LU0320764755.SGD","03037","LU0106959298.USD","LU0823434740.USD","LU2089283258.USD","LU2506951792.HKD","LU1366333091.USD","LU0820561909.HKD","LU0348827113.USD","IE0009G5SDU7.USD","IE00B775SV38.USD","IE00BN29S564.USD","LU0154236417.USD","LU1770036033.HKD","LU2778985437.USD","LU0819123356.HKD","HK0000151867.HKD","LU0651947912.USD","IE00BK4W5M84.HKD","LU1400636574.HKD","LU1548497426.USD","LU0882574139.USD","LU0795875169.SGD","LAZR","LU1974910355.USD","LU0726765562.USD","LU2242650005.HKD","LU0234572021.USD","LU0210536198.USD","BK4533","LU3063872942.SGD","LU0787776722.HKD","LU0384037296.USD","SGXZ31699556.SGD","LFGY","IE00BD6J9T35.USD","LU0266013472.USD","LU0912757837.SGD","SMH","BK1249","LU0359201612.USD","IE00BFSS7M15.SGD","BK4579","LU1282651121.HKD","LU1496350171.SGD","LU1769817179.HKD","LU2461242641.AUD","LU1202635105.USD","LU0210533765.USD","LU0868494617.USD","IE000ITXATA3.USD","LU1048484197.HKD","NVDQ","LU0348825331.USD","LU0607220059.USD","LU0648948544.HKD","LU0861579265.USD","ROM","HK0000320223.HKD","LU0353189680.USD","LU1935042488.USD","LU0823413587.USD","LU0214875030.USD","LU2023250330.USD","LU1934455277.USD","SG9999004220.SGD","LU0791590937.USD","LU0164865239.USD","NVDG","BK1615","HK0000306701.USD","LU1979441026.SGD","LU2083900584.USD","SNVD.UK","SG9999015358.SGD","LU0630378692.HKD","LU0197773673.USD","LU0128522157.USD","LU0762541174.USD","LU2462591277.SGD","FAI","LU0109392836.USD","LU2360106780.USD","LU2361045086.USD","LU2552382215.SGD","LU0203202063.USD","LU2242649171.HKD","LU0174119429.USD","LU2452424414.USD","IE0001KFT4U8.USD","LU1645745479.HKD","LU1244550221.USD","LU0128522744.USD","IE00BZ199S13.USD","LU0205193047.USD","LU0683600562.USD","LU0441854154.USD","LU1144417596.USD","07300","FDNI","LU1815333072.USD","LU2322448791.USD","LU2357125470.USD","LU2360032135.SGD","IE00B3M56506.USD","LU0965509283.SGD","LU1670756490.USD","XLK","IE0009356076.USD","LU0342679015.USD","LU2125909916.SGD","LU2097829019.USD","SGXZ81514606.USD","LU1923623000.USD","BK4592","LU0348784397.USD","LU0708995153.HKD","LU2326559502.SGD","LU1504937902.USD","LU2552382132.HKD","SG9999015945.SGD","HK0000286598.CNH","LU0348783662.USD","LU0737861699.HKD","LU1115378108.SGD","LU1914381329.SGD","SOXQ","LU2279689827.SGD","LU1861127337.USD","HK0000165453.HKD","LU0048388663.USD","IE0005OL40V9.USD","LU0499858602.USD","LU1496350502.SGD","LU2237443895.HKD","LU2152927971.USD","IE00B4JS1V06.HKD","LU2272731865.HKD","LU0985320562.USD","IE00B7KXQ091.USD","LU0132412106.USD","COHX","LU0314109678.HKD","IE000W1ABFV2.USD","LU1023057109.AUD","LU0353189763.USD","LU0043850808.USD","LU2125909247.SGD","BKF","CHPX","LU0187121727.USD","LU0251144936.SGD","LU1791710582.SGD","LU0077335932.USD","LU1116320737.USD","LU1429558221.USD","LU0898667661.SGD","NVIW.SI","IE00BKDWB100.SGD","LU1224709979.USD","LU2491049909.HKD","LU2488822045.USD","LU0070217475.USD","LU0823397285.USD","BK4554","LU0577902454.USD","LU0786609619.USD","LU0348814723.USD","SG9999014559.SGD","LU2746668461.USD","LU0084288322.USD","COHR","LU0265550946.USD","LU2473716301.USD","07388","LU1282651048.USD","LU3102509885.SGD","LU1831875114.USD","SGXZ86797644.SGD","LU2111349929.HKD","LU0133085943.USD","MCHmain","LU2100268510.USD","CMAG","LU0096374516.USD","LU0345775950.USD","LU2361044865.SGD","LU0264606111.USD","SG9999001903.USD","SG9999014906.USD","LU0823421416.USD","CNEQ","LU2394011477.USD","IE00BMPRXN33.USD","LU0499858438.USD","LU1880398554.USD","LU2456880835.USD","LU0611395673.USD","LU0289961442.SGD","LU2213496289.HKD","LU1880398471.USD","SG9999017495.SGD","LU2065171402.SGD","IE000Q6AESB8.SGD","IE00B0169N27.USD","LU0370786039.SGD","LU1242518857.USD","LU1267930490.SGD","LU0543330483.HKD","LU0396098781.USD","LU0700851271.USD","LU1642822792.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662276478","title":"Hong Kong's SSY Group H1 Profit Rises on Infusion Solutions Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2662276478","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662276478?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:16","pubTimestamp":1787717785,"startTime":"0","endTime":"0","summary":"Hong Kong's SSY Group H1 profit rises on infusion solutions growthOverviewHong Kong pharmaceutical maker's H1 revenue rose 9.9% yr/yr to HK$2,361 mlnNet profit attributable to shareholders rose 13% to","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N037:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828805.USD","LU0326950275.SGD","BK1161","LU2242644610.SGD","LU2328871848.SGD","LU2097828474.EUR","HK0000165453.HKD","BK1583","BK1191","KURE","LU1969619763.USD","LU0463099449.HKD","01801","LU2097828631.EUR","LU0502904849.HKD","LU2460026573.USD","LU0244354667.USD","BK1589","LU1188198961.HKD","02005","LU2097828714.EUR","LU2097828557.USD","LU2488822045.USD","LU0455707207.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662176420","title":"Sihuan Pharmaceutical H1 Profit Jumps on Medical Aesthetics Unit Strength","url":"https://stock-news.laohu8.com/highlight/detail?id=2662176420","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662176420?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:15","pubTimestamp":1787717732,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical H1 profit jumps on medical aesthetics unit strengthOverviewChina pharmaceutical group's interim revenue rose 1.3% yr/yr, led by medical aesthetics growthNet income attributable t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N039:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801","BK1593","HK0000165453.HKD","LU2488822045.USD","BK1191","LU0314109678.HKD","688428","BK1589","LU0067412154.USD","01093","IE00BZ08YS42.EUR","IE0008369823.USD","LU0455707207.USD","LU1188198961.HKD","LU1226288170.HKD","LU1328277881.USD","LU1226287529.USD","LU2097828714.EUR","LU1807302812.USD","LU0244354667.USD","BK0239","LU1960683339.HKD","LU2097828631.EUR","BK1600","LU1008478684.HKD","LU2242644610.SGD","LU1226288253.USD","LU1969619763.USD","LU0140636845.USD","LU2039709279.SGD","LU0072913022.USD","LU1813983027.USD","LU2328871848.SGD","LU0502904849.HKD","00460","KURE","IE00B5MMRT66.SGD","LU0463099449.HKD","LU0501845795.SGD","SG9999004220.SGD","IE00B543WZ88.USD","LU0880133367.SGD","IE00B031HY20.USD","LU2097828474.EUR","LU2097828805.USD","BK1583","LU1152091754.HKD","BK1515","BK1161","LU1152091168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154655464","title":"Morning Market Wrap: Hong Kong Shares Rise 0.68% as Copper Stocks Take the Lead","url":"https://stock-news.laohu8.com/highlight/detail?id=1154655464","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154655464?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:07","pubTimestamp":1787717221,"startTime":"0","endTime":"0","summary":"Hong Kong's benchmark index kicked off the morning session with a 0.68% gain, advancing 174 points to reach 25,685 points, while the tech-heavy Hang Seng Tech Index climbed a more robust 1.58%....","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06185","LU1328277881.USD","LU1481107354.HKD","LU0540923850.HKD","LU1961090484.USD","BK1574","IE00BGHQDM52.EUR","06166","02833","03088","BK1191","BK1580","LU2039709279.SGD","LU0359201612.USD","09088","KURE","02313","LU0140636845.USD","LU1102505929.USD","SG9999004220.SGD","LU0348766576.USD","SG9999004311.SGD","688185","LU2213484517.USD","07552","IE00BVYPNP33.GBP","82800","IE00BZ08YT58.USD","07300","LU0181495838.USD","LU0417516738.SGD","LU2929501877.USD","LU0890818403.SGD","00358","03419","03115","IE0031814852.USD","LU1102505762.USD","LU2045819591.USD","LU2187417386.USD","LU0244354667.USD","600999","LU0405327494.USD","BK1190","03908","LU0149534421.HKD","LU1720050803.USD","LU2476274308.USD","BK1553","SG9999002950.SGD","BK1597","LU0348735423.USD","IE00BMCWC346.EUR","LU1813983027.USD","HK0000286598.CNH","03423","IE00BVYPNQ40.USD","IE0008368742.USD","LU0607220059.USD","SG9999002828.SGD","06831","06969","IE00B031J352.USD","IE00B5MMRT66.SGD","IE00BZ08YS42.EUR","HTImain","BK1501","IE00BPRC5H50.USD","BK1206","MCHmain","LU0359202008.SGD","LU0605514214.HKD","LU0359201885.HKD","LU0828237940.HKD","LU0348784397.USD","BK1564","LU0650527681.SGD","LU1023057109.AUD","LU0862451837.USD","BK1594","BK1589","BK1184","01828","HHImain","LU0594300419.USD","BK1240","01112","IE00B031HY20.USD","LU1048596156.SGD","LU1880383366.USD","03033","BK1592","LU0821914370.USD","LU0052750758.USD","BK1227","BK1513","LU1188198961.HKD","09926","IE00B29SXG58.USD","LU0417516571.SGD","603993","BK1233","600362","LU2778985437.USD","IE00BYV24P56.USD","603083","BK1516","LU0634319403.HKD","09067","HSImain","LU1831875114.USD","HSTECH","LU0326950275.SGD","LU0561508036.HKD","LU2476274720.SGD","BK1237","LU1794554557.SGD","LU2125910500.SGD","601995","01258","BK1242","LU0348827113.USD","LU0348783233.USD","BK1568","IE00BZ08YR35.GBP","LU0862451753.SGD","07226","BK1149","BK1147","IE00B543WZ88.USD","07500","03032","SG9999014674.SGD","03037","02575","LU2488822045.USD","LU0348767384.USD","LU0348825331.USD","LU0314109678.HKD","03993","LU0405327148.USD","BK1515","IE0008369823.USD","LU1880383440.USD","LU2351347302.SGD","LU0417516902.SGD","09115","BK1521","LU0164880469.USD","LU0463099449.HKD","LU0594300179.USD","06099","LU0708995583.HKD","BK1161","02800","HSI","02837","83115","LU0149721374.USD","LU0320764599.SGD","LU2399975544.HKD","03067","513600","03417","07200"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128522297","title":"Mainland Benchmarks Edge Higher in Morning Trade; Nonferrous Metals and Brokerages Lead While Optical Modules Retreat; Hang Seng and Tech Index Climb Over 1% on Biotech Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1128522297","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128522297?lang=en_us&edition=fundamental","pubTime":"2026-08-26 10:38","pubTimestamp":1787711889,"startTime":"0","endTime":"0","summary":"Mainland Chinese equities extended gains on August 26, with all three major indices moving higher in early trading. Precious and base metals sustained their upward momentum, while brokerages and...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828557.USD","03037","161726","LU1993786604.SGD","HSI","LU2328871848.SGD","LU2488822045.USD","HK0000165453.HKD","03032","82800","000001","09067","BK0278","03067","07226","BK1589","LU0880133367.SGD","LU0501845795.SGD","02833","LU1781817850.SGD","BK0028","07300","LU1580142542.USD","03033","LU0463099449.HKD","LU0072913022.USD","LU1969619763.USD","LU2097828714.EUR","IE00B0JY6N72.USD","LU2097828631.EUR","LU2242644610.SGD","LU0455707207.USD","01801","LU2097828805.USD","BK1161","07500","BK0012","HTImain","02837","03419","07200","09088","BK0183","BK0187","HHImain","KURE","LU0067412154.USD","07552","BK1583","03423","02800","LU1226287529.USD","83115","LU1655091616.SGD","BK0188","09115","513600","HSTECH","MCHmain","HSImain","LU1807302812.USD","LU0244354667.USD","LU1188198961.HKD","LU0326950275.SGD","03088","03417","BK0201","LU0502904849.HKD","03115","LU2097828474.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662769060","title":"China's Akeso Jumps on Progress of Immunotherapy Drug for Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2662769060","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662769060?lang=en_us&edition=fundamental","pubTime":"2026-08-26 10:33","pubTimestamp":1787711596,"startTime":"0","endTime":"0","summary":"BUZZ-China's Akeso jumps on progress of immunotherapy drug for cancer treatment** Shares of China-based drug developer Akeso Inc9926.HKjump 9% to HK$96.9, on track for the biggest one-day pct gain since June 29** Stock hits the highest level since August 20 in the second gaining session** Akeso saysivonescimab plus chemomeets primary endpoint with significant overall survival benefit versus durvalumab plus chemo in phase III clinical study for the first-line treatment of advanced biliary tract cancer** The study met all key secondary endpoints of progression-free survival and objective response rate - Co** YTD, stock down 14.8%, while Hang Seng Biotech Index.HSBIOup 15.7%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N025:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417516902.SGD","LU2488822045.USD","IE00B5MMRT66.SGD","LU2476274308.USD","LU0634319403.HKD","LU0417516571.SGD","LU0561508036.HKD","LU0417516738.SGD","LU2476274720.SGD","LU0348783233.USD","KURE","LU0348825331.USD","LU1720050803.USD","BK1161","LU0348784397.USD","LU2778985437.USD","09926","LU1794554557.SGD","LU0348735423.USD","LU0348766576.USD","IE00BPRC5H50.USD","LU2399975544.HKD","LU0348827113.USD","IE00B543WZ88.USD","LU1961090484.USD","LU0348767384.USD","BK1574","LU0540923850.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147226125","title":"AKESO Surges Over 9% in Session as Evonex Achieves Positive Phase III Results in Biliary Tract Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1147226125","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147226125?lang=en_us&edition=fundamental","pubTime":"2026-08-26 10:31","pubTimestamp":1787711462,"startTime":"0","endTime":"0","summary":"Shares of AKESO (09926) surged more than 9% during intraday trading before paring gains to trade 6.81% higher at HK$94.85, with turnover reaching HK$814 million. The sharp move followed the company's...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BPRC5H50.USD","BK1161","LU0540923850.HKD","LU0417516902.SGD","BK4134","LU0417516571.SGD","LU0348784397.USD","LU2488822045.USD","LU0348783233.USD","LU0561508036.HKD","LU0348766576.USD","LU1961090484.USD","LU0348825331.USD","LU2476274720.SGD","LU0348827113.USD","III","LU1794554557.SGD","LU1720050803.USD","09926","LU0348767384.USD","LU0348735423.USD","LU0634319403.HKD","LU2778985437.USD","LU0417516738.SGD","IE00B5MMRT66.SGD","LU2476274308.USD","IE00B543WZ88.USD","KURE","BK1574","LU2399975544.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662766269","title":"Akeso's Ivonescimab Meets Primary Endpoint in Phase 3 Biliary Tract Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662766269","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662766269?lang=en_us&edition=fundamental","pubTime":"2026-08-26 09:41","pubTimestamp":1787708502,"startTime":"0","endTime":"0","summary":"Akeso  said its PD-1/VEGF bispecific antibody ivonescimab plus chemotherapy met the primary endpoint in a Phase 3 trial for first-line treatment of advanced biliary tract cancer.The trial met its primary endpoint of overall survival, with key secondary endpoints of progression-free survival and objective response rate also met, according to a Wednesday filing with the Hong Kong bourse.The HARMONi-GI1 study enrolled 682 patients, marking ivonescimab's first positive Phase 3 result in gastrointestinal tumors, Akeso said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1794554557.SGD","KURE","LU0417516738.SGD","LU0348784397.USD","IE00BPRC5H50.USD","LU0348735423.USD","LU0348766576.USD","IE00B5MMRT66.SGD","LU2488822045.USD","LU0348827113.USD","LU2778985437.USD","LU1720050803.USD","LU0348783233.USD","LU0417516902.SGD","LU0561508036.HKD","LU0348825331.USD","LU0348767384.USD","LU2476274720.SGD","09926","IE00B543WZ88.USD","LU1961090484.USD","LU0634319403.HKD","LU2476274308.USD","LU0540923850.HKD","LU2399975544.HKD","BK1161","LU0417516571.SGD","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662766696","title":"Akeso Says Ivonescimab Plus Chemo Meets Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2662766696","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662766696?lang=en_us&edition=fundamental","pubTime":"2026-08-26 09:29","pubTimestamp":1787707747,"startTime":"0","endTime":"0","summary":"BRIEF-Akeso Says Ivonescimab Plus Chemo Meets Primary EndpointAug 26 (Reuters)-Akeso Inc9926.HK:IVONESCIMAB PLUS CHEMO MEETS PRIMARY ENDPOINT WITH SIGNIFICANT OS BENEFIT IN 1L BTCFurther company coverage:9926.HK","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44M0TW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1794554557.SGD","LU2778985437.USD","BK1161","BK1574","LU2476274308.USD","LU0417516738.SGD","LU1961090484.USD","LU0540923850.HKD","LU0417516902.SGD","LU0348784397.USD","LU0417516571.SGD","LU0348825331.USD","LU0561508036.HKD","LU0348767384.USD","IE00B5MMRT66.SGD","KURE","09926","LU0348783233.USD","LU0348735423.USD","LU2488822045.USD","LU2399975544.HKD","IE00BPRC5H50.USD","LU0634319403.HKD","LU0348827113.USD","LU0348766576.USD","LU1720050803.USD","LU2476274720.SGD","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}